Pseudohypoparathyroidism Ia and hypercalcitoninemia
- PMID: 11443172
- DOI: 10.1210/jcem.86.7.7690
Pseudohypoparathyroidism Ia and hypercalcitoninemia
Abstract
Pseudohypoparathyroidism Ia (PHP Ia) is characterized by resistance to PTH and many other stimuli because of deficiency of stimulatory G protein alpha-subunit. To determine the incidence, natural history, and mechanism of C cell dysfunction in PHP, calcitonin assays were performed in six patients with PHP Ia and four with pseudopseudohypoparathyroidism from three unrelated families. Controls included healthy subjects and patients with PHP Ib or hypoparathyroidism. The mean basal level of calcitonin was higher in PHP Ia patients than in controls (95.3 +/- 112.7 vs. 3.7 +/- 2.4 pg/mL; P = 0.005; n < 10). In PHP Ia patients, calcitonin levels rose over the normal range (30 pg/mL) after pentagastrin infusion in five patients and remained normal in one. Familial medullary thyroid carcinoma was clinically, biologically, and ultrasonographically ruled out over a mean follow-up exceeding 3 yr. Genomic screening for RET protooncogene mutations failed to reveal any anomaly. The calcitonin infusion test, which induced a significant increase in plasma cAMP in controls 30 and 60 min after infusion, failed to produce this response in PHP Ia patients, suggesting that the action of calcitonin was specifically impaired. PHP Ia may therefore be an independent etiology of hypercalcitoninemia and hyperresponsiveness to pentagastrin infusion.
Similar articles
-
Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?Thyroid. 1998 Sep;8(9):781-5. doi: 10.1089/thy.1998.8.781. Thyroid. 1998. PMID: 9777749
-
Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.J Clin Endocrinol Metab. 2001 Aug;86(8):3746-53. doi: 10.1210/jcem.86.8.7767. J Clin Endocrinol Metab. 2001. PMID: 11502806
-
Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.World J Surg. 2002 Oct;26(10):1286-90. doi: 10.1007/s00268-002-6487-1. Epub 2002 Sep 4. World J Surg. 2002. PMID: 12205548
-
GNAS locus and pseudohypoparathyroidism.Horm Res. 2005;63(2):65-74. doi: 10.1159/000083895. Epub 2005 Feb 9. Horm Res. 2005. PMID: 15711092 Review.
-
GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?Horm Metab Res. 2012 Sep;44(10):716-23. doi: 10.1055/s-0032-1314842. Epub 2012 Jun 6. Horm Metab Res. 2012. PMID: 22674477 Review.
Cited by
-
Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.Nat Rev Endocrinol. 2016 Jun;12(6):347-56. doi: 10.1038/nrendo.2016.52. Epub 2016 Apr 22. Nat Rev Endocrinol. 2016. PMID: 27109785 Review.
-
Infant With Pseudohypoparathyroidism Type 1a, Misdiagnosed as Congenital Hypothyroidism.Med Arch. 2023 Feb;77(1):70-73. doi: 10.5455/medarh.2023.77.70-73. Med Arch. 2023. PMID: 36923733 Free PMC article. Review.
-
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0. Nat Rev Endocrinol. 2018. PMID: 29959430 Free PMC article. Review.
-
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.J Clin Endocrinol Metab. 2025 Apr 22;110(5):1334-1341. doi: 10.1210/clinem/dgae416. J Clin Endocrinol Metab. 2025. PMID: 38940443 Free PMC article.
-
Pseudohypoparathyroidism.Endocrinol Metab Clin North Am. 2018 Dec;47(4):865-888. doi: 10.1016/j.ecl.2018.07.011. Epub 2018 Oct 12. Endocrinol Metab Clin North Am. 2018. PMID: 30390819 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources